Detection of anti-IFI16 antibodies by ELISA: Clinical and serological associations in systemic sclerosis

Rheumatology

Volumn 50, Issue 4, 2011, Pages 674-681

  Costa, Silvia ^a,b   Mondini, Michele ^a,b,c   Caneparo, Valeria ^a   Afeltra, Antonella ^c,d   Airò, Paolo ^e   Bellisai, Francesca ^f   Faggioli, Paola ^g   Gerli, Roberto ^c,h   Lotzniker, Milvia ^c,g   Meroni, Pier L ^c,i   Morozzi, Gabriella ^c,f   Radice, Antonella ^c,j   Riccieri, Valeria ^c,k   Scarsi, Mirko ^e   Sebastiani, Gian D ^c,l   Sinico, Renato A ^c,j   Tincani, Angela ^c,e   Gariglio, Marisa ^a,l   Landolfo, Santo ^m  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b NoToPharm Srl   (Italy)

^c Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) group   (Italy)

^d UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f UNIVERSITY OF SIENA   (Italy)

^g AO Ospedale Civile   (Italy)

^h UNIVERSITY OF PERUGIA   (Italy)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j SAN CARLO BORROMEO HOSPITAL   (Italy)

^k SAPIENZA UNIVERSITY OF ROME   (Italy)

^l ACO San Filippo Neri   (Italy)

^m UNIVERSITY OF TURIN   (Italy)

more..

Author keywords

Autoantibodies; Diagnosis; IFI16; Interferon; Systemic sclerosis

Indexed keywords

ANTIBODY; INTERFERON INDUCIBLE 16 ANTIBODY; RNA POLYMERASE III ANTIBODY; SCL 70 ANTIBODY; TOPOISOMERASE I ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS;

AGED; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DNA TOPOISOMERASES, TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PHOSPHOPROTEINS; RNA, BACTERIAL; SCLERODERMA, SYSTEMIC;

EID: 79952776947     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq372     Document Type: Article

References (23)

1. Abraham DJ, Krieg T, Distler J, Distler O. Overview of pathogenesis of systemic sclerosis. Rheumatology 2009; 48(Suppl. 3):iii3-7.
2. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
3. Ziswiler HR, Urech R, Balmer J, Ostensen M, Mierau R, Villiger PM. Clinical diagnosis compared to classification criteria in a cohort of 54 patients with systemic sclerosis and associated disorders. Swiss Med Wkly 2007;137: 586-90.
4. Tormey VJ, Bunn CC, Denton CP, Black CM. Anti-fibrillarin antibodies in systemic sclerosis. Rheumatology 2001;40: 1157-62.
5. Codullo V, Cavazzana I, Bonino C et al. Serologic profile and mortality rates of scleroderma renal crisis in Italy. J Rheumatol 2009;36:1464-9.
6. Gariglio M, Azzimonti B, Pagano M et al. Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. J Interferon Cytokine Res 2002;22:815-21.
7. Mondini M, Costa S, Sponza S, Gugliesi F, Gariglio M, Landolfo S. The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity. Autoimmunity 2010;43:226-31.
8. Caposio P, Gugliesi F, Zannetti C et al. A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells. J Biol Chem 2007; 282:33515-29.
9. Raffaella R, Gioia D, De Andrea M et al. The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells. Exp Cell Res 2004;293:331-45.
10. Mondini M, Vidali M, De Andrea M et al. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16. Arthritis Rheum 2006;54: 3939-44.
11. Seelig HP, Ehrfeld H, Renz M. Interferon-gamma-inducible protein p16. A new target of antinuclear antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1994;37:1672-83.
12. Uchida K, Akita Y, Matsuo K et al. Identification of specific autoantigens in Sjogren's syndrome by SEREX. Immunology 2005;116:53-63.
13. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
14. Walker UA, Tyndall A, Czirják L et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2007;66:754-63.
15. Codullo V, Morozzi G, Bardoni A et al. Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis. Clin Exp Rheumatol 2007;25:373-7.
16. Meyer OC, Fertig N, Lucas M, Somogyi N, Medsger TA Jr. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol 2007;34:104-9.
17. Parker JC, Burlingame RW, Webb TT, Bunn CC. Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA. Rheumatology 2008;47:976-9.
18. Meyer O, De Chaisemartin L, Nicaise-Roland P et al. Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study. J Rheumatol 2010;37:125-30.
19. Kahan A, Coghlan G, McLaughlin V. Cardiac complications of systemic sclerosis. Rheumatology 2009; 48(Suppl. 3):iii45-8.
20. Wells AU, Steen V, Valentini G. Pulmonary complications: one of the most challenging complications of systemic sclerosis. Rheumatology 2009;48(Suppl. 3):iii40-4.
21. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005;35:35-42.
22. Mitri GM, Lucas M, Fertig N, Steen VD, Medsger TA Jr. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum 2003;48:203-9.
23. Wei W, Clarke CJ, Somers GR et al. Expression of IFI 16 in epithelial cells and lymphoid tissues. Histochem Cell Biol 2003;119:45-54.